TY - JOUR
T1 - Application of Multifunctional Nanomaterials in Radioprotection of Healthy Tissues
AU - Xie, Jiani
AU - Wang, Chengyan
AU - Zhao, Feng
AU - Gu, Zhanjun
AU - Zhao, Yuliang
N1 - Funding Information:
J.X. and C.W. contributed equally to this work. This work was supported by the National Basic Research Program of China (Grant No. 2016YFA0201600), the National Natural Science Foundation of China (Grant Nos. 51772292, 31571015, 11621505, 11435002, and 21320102003), the Key Research Program of Frontier Sciences (Grant No. QYZDJ-SSW-SLH022), and the Youth Innovation Promotion Association, CAS (Grant No. 2013007).
Publisher Copyright:
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
PY - 2018/10/24
Y1 - 2018/10/24
N2 - Radiotherapy has been extensively used in clinic for malignant tumors treatment. However, a severe challenge of it is that the ionizing radiation needed to kill tumors inevitably causes damage to surrounding normal tissues. Although some of the molecular radioprotective drugs, such as amifostine, have been used as clinical adjuvants to radio-protect healthy tissues, their shortcomings such as short systemic circulation time and fast biological clearing from the body largely hinder the sustained bioactivity. Recently, with the rapid development of nanotechnology in the biological field, the multifunctional nanomaterials not only establish powerful drug delivery systems to improve the molecular radioprotective drugs' biological availability, but also open a new route to develop neozoic radioprotective agents because some nanoparticles possess intrinsic radioprotective abilities. Therefore, considering these overwhelming superiorities, this review systematically summarizes the advances in healthy tissue radioprotection applications of multifunctional nanomaterials. Furthermore, this review also points out a perspective of nanomaterial designs for radioprotection applications and discusses the challenges and future outlooks of the nanomaterial-mediated radioprotection.
AB - Radiotherapy has been extensively used in clinic for malignant tumors treatment. However, a severe challenge of it is that the ionizing radiation needed to kill tumors inevitably causes damage to surrounding normal tissues. Although some of the molecular radioprotective drugs, such as amifostine, have been used as clinical adjuvants to radio-protect healthy tissues, their shortcomings such as short systemic circulation time and fast biological clearing from the body largely hinder the sustained bioactivity. Recently, with the rapid development of nanotechnology in the biological field, the multifunctional nanomaterials not only establish powerful drug delivery systems to improve the molecular radioprotective drugs' biological availability, but also open a new route to develop neozoic radioprotective agents because some nanoparticles possess intrinsic radioprotective abilities. Therefore, considering these overwhelming superiorities, this review systematically summarizes the advances in healthy tissue radioprotection applications of multifunctional nanomaterials. Furthermore, this review also points out a perspective of nanomaterial designs for radioprotection applications and discusses the challenges and future outlooks of the nanomaterial-mediated radioprotection.
KW - multifunctional nanomaterials
KW - nanocarriers
KW - nanoradioprotectors
KW - radioprotection
KW - radioprotective mechanisms
UR - http://www.scopus.com/inward/record.url?scp=85050848929&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85050848929&partnerID=8YFLogxK
U2 - 10.1002/adhm.201800421
DO - 10.1002/adhm.201800421
M3 - Review article
C2 - 30019546
AN - SCOPUS:85050848929
SN - 2192-2640
VL - 7
SP - e1800421
JO - Advanced Healthcare Materials
JF - Advanced Healthcare Materials
IS - 20
M1 - 1800421
ER -